Status:

COMPLETED

Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo

Lead Sponsor:

Hospital Universitario Dr. Jose E. Gonzalez

Conditions:

Vitiligo

Vitiligo, Generalized

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

A randomized clinical trial that treats vitiligo patients with oral vitamin D and Narrow-Band Ultraviolet B (NB-UVB) phototherapy (intervention group); or placebo and NB-UVB phototherapy (control grou...

Detailed Description

A randomized clinical trial, triple-blind, placebo-controlled treating patients with diagnosed vitiligo. The intervention group will be treated with oral vitamin D 5,000 IU per day and NB-UVB photothe...

Eligibility Criteria

Inclusion

  • Males or females, ≥ 18 years of age at the time of signing the informed consent document.
  • ≥5% of affected skin area
  • Inactive, generalized vitiligo (inactive for a minimum of 6 months). \[Inactive: No new spontaneous lesions or a rapid progression of these.\]
  • Subjects who have not been treated with phototherapy previously.
  • Subject who have not been treated with topical corticosteroids for at least 8 weeks or immunomodulators for at least 12 weeks.

Exclusion

  • Subjects with \<5% of affected skin area
  • Subjects who use multivitamins, diuretics, lipase-inhibitors (orlistat)
  • Subjects with calcium disorders (for example: primary hyperparathyroidism) or patients with hepatic/kidney failure.
  • Subjects with malabsorption gastrointestinal disorders
  • Pregnant women or in lactation
  • Subjects with cancer
  • Subjects with previous history of skin cancer (melanoma/non-melanoma)
  • Photo-sensible diseases (actinic dermatitis, porphyria, xeroderma pigmentosa) or drugs
  • Subjects using immunomodulator o immunosuppressor treatments
  • Subjects who practice activities that require prolonged sun exposure.

Key Trial Info

Start Date :

September 14 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2022

Estimated Enrollment :

26 Patients enrolled

Trial Details

Trial ID

NCT04872257

Start Date

September 14 2021

End Date

November 1 2022

Last Update

February 14 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Universitario "Dr. Jose Eleuterio Gonzalez"

Monterrey, Nuevo León, Mexico, 64460